A patient who sustained aphasia due to amyotrophic lateral sclerosis has regained the ability to communicate after receiving a brain-machine interface implant, a hospital in Beijing announced on ...

Neurizon Therapeutics (ASX:NUZ) has shared an update on its preparations for its HEALEY ALS Platform Trial – a multicentre, ...

Public safety officers from across West Michigan held a charity hockey game on Saturday to raise awareness and funds for ...

In one tiny town, more than a dozen people were diagnosed with the rare neurodegenerative disease ALS. Why? I n March 2009, ...

R, a BCI headset that helps late-stage ALS patients communicate. Learn how this innovative technology is restoring voices.

A team of researchers from the Universitat Politècnica de València (UPV) and the French National Center for Scientific ...

PrimeC is NeuroSense's lead drug candidate for ALS, a novel extended-release oral formulation combining ciprofloxacin and celecoxib. The drug has demonstrated promising results in clinical trials, ...

Famed physicist Stephen Hawking took gravity to its ultimate limits. In doing so, he made a number of significant ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Cognixion is recruiting adults with ALS for a clinical trial testing BCI headset ONE Axon-R as a communication aid.

The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical ...

Lorem, a nonprofit foundation, today announced that nine patients with an ultra-rare type of amyotrophic lateral sclerosis (ALS) have been treated during the first year of a multi-year grant from the ...